Submissions

Author Guidelines

Instructions to Authors

The mission of the Journal of Vascular and Interventional Neurology is to promote dissemination of new information related to the field of neurovascular medicine. The scope of the journal includes basic science, diagnosis, treatment, rehabilitation, disease prevention, epidemiology, and health care administration. Articles are published in a variety of formats: reviews, reports of original research, case reports, technical notes, letters, rebuttals, and editorials. To the extent that current technology allows, the journal is published on the Internet, and supplemental materials such as videos, 3-D renderings, software, and hypertext links are made available electronically. We welcome manuscripts from outside the United States.

We perform single-blind review  of submitted manuscripts. The authors’ identities and affiliations are known to reviewers. Making this information available to reviewers ensures that reviewers can identify any potential conflict of interest and recuse themselves if appropriate.

However authors can opt for double-blind review of manuscript on request at the time of submission of manuscript.

Please also familiarize yourself with our policies and ethics guidelines (last updated 8/16/2020).

Authors are invited to submit their materials through the submission system of the journal 

for any further inquiry please send contact 

Managing Editor

Journal of Vascular and Interventional Neurology

14 13th street S,

Sauk Rapids, MN 56379

email: manager@jvin.info

Submit the following:

•     Title.
•     Full names of all authors, including professional or academic suffixes (MD, PhD, etc.).
•     A brief justification for inclusion of each author. Authorship should be limited to those persons who have contributed original professional or intellectual content to the submitted material. The following are examples of activities that do not warrant authorship: allowing access to one’s patients, performing standard medical care, following written or verbal instructions, providing administrative or financial support, and editing for language or style.
•     Address and e-mail contact for the corresponding author.
•     Institution(s) from which the work originated.
•     Financial sponsorships, if any.
•     Disclosure of any potentially significant conflicts of interest.
•     An abstract limited to 300 words or 10% of the text length (excluding references), whichever is shorter.
•     A list of abbreviations used 2 or more times, along with their interpretation, in the order that they are used in the text. Abbreviations for common units of measure (e.g., mm, Kg, sec) need not be listed.

    All hematological and clinical chemistry measurements should be reported in the metric system in terms of the International System of Units (SI). Alternative or non-SI units should be added in parenthesis.

    Manuscripts are preferred in Word ( .doc) format however, are not restricted to only one type of format as mentioned earlier. All text must be double spaced. Use the American spellings. Reserve the word “ significant “ and “ non significant” for statistics. Authors are encouraged to proof read all edited manuscripts carefully. Authors are responsible for all statements published in their work including any changes made by the editor.

    A list of commercial products, in the order that they appear in the text, including the trade name, the registry symbol (if any; usually ® or ™), full name of the manufacturer, and the manufacturer’s city, state (or other equivalent subdivision), and country.

    The text of the report. Traditional sections such as introduction, materials and methods, results, discussion, and conclusions, are recommended but not required.

    Acknowledgments, if any. Include disclosures of any copyrighted material that has been used with permission.

  Clinical trials should be registered with a publicly accessible clinical trial registry, such as http://www.clinicaltrials.gov. Registration number and registry URL should be supplied when submitting the manuscript. However, studies that are designed for other purposes, such as to study pharmacokinetics or major toxicity (e.g. phase 1 trials), are exempt. When reporting randomized controlled trials, please adhere to the CONSORT (Consolidated Standards of Reporting Trials) statement (http://www.consort-statement.org)

  A list of references, numbered in the order that they appear in the text. Refer to a past issue of the Journal of Vascular and Interventional Neurology to ascertain format or visit www.jvin.org

  Tables, numbered in the order in which they are referenced in the text. Each table must have a brief title, and may have a caption.

  Figures, numbered in the order in which they are referenced in the text. Each figure must have a brief title, and may have a legend. Digital line drawings should have a resolution of at least 600 dpi, digital gray-scale or color figures should be at least 200 dpi.

The authors are notified with the reference number upon manuscript registration at the Editorial Office. We encourage authors to suggest the names of possible reviewers, but we reserve the right of final selection. The evaluation process usually takes 2 to 4 weeks. Submitted papers are accepted for publication after a positive opinion of the independent reviewers.

When reporting experiments on human subjects, please indicate whether the procedures were approved by the ethical standards committee on human experimentation (institutional or regional). Authors must comply with the guidelines of the International Committee of Medical Journal Editors http:// www.icmje.org with regard to patient consent for research. Do not use identifying information such as patients’ names, initials, or hospital numbers anywhere in the manuscript (including figures). Authors are responsible for obtaining patient consent for any figure of a recognizable patient.

Manuscripts should be submitted in English, in the style of the American Medical Association (AMA). Please consult AMA Manual of Style, 10th Edition. Oxford University Press.

Items submitted for publication will be professionally reviewed and edited, and modifications may be requested. If an item is accepted for publication, all authors must submit the copyright to the published materials. The editors have final judgment on whether the material is published in the Journal of Vascular and Interventional Neurology.